ArticleCancers2025

The Association Between Location of BRCA Mutation and Efficacy of PARP Inhibitor as a Frontline Maintenance Therapy in Advanced Epithelial Ovarian Cancer.

Ji Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.